Newly synthesized piperazine derivatives as tyrosinase inhibitors: in vitro and in silico studies
作者:Cigdem Dokuzparmak、Fulya Oz Tuncay、Serap Basoglu Ozdemir、Busra Kurnaz、Ilke Demir、Ahmet Colak、Safiye Sag Erdem、Nuri Yildirim
DOI:10.1007/s13738-021-02487-3
日期:2022.7
respectively. 10b (Ki = 9.54 µM, mixed type inhibition) with the lowest IC50 value among derivatives was selected to determine kinetic constants and inhibition types. Furthermore, molecular docking analysis was performed for all compounds and it was observed that 4b, 5a, 4c, and 10b showed promising inhibitory effect on tyrosinase activity. Based on docking results, ADME predictions and in vitro studies, 10b
在这项研究中,合成了一系列以哌嗪为基本骨架的新型有机化合物,并通过体外和计算机研究评估了它们的酪氨酸酶抑制潜力。体外研究表明,具有 1、2、4、三唑核的化合物 10a 和 10b 可被认为是有效的酪氨酸酶抑制剂,IC50 值分别为 31.2 ± 0.7 和 30.7 ± 0.2 µM。选择衍生物中IC50值最低的10b(Ki = 9.54 µM,混合型抑制)来确定动力学常数和抑制类型。此外,对所有化合物进行了分子对接分析,观察到 4b、5a、4c 和 10b 对酪氨酸酶活性具有良好的抑制作用。根据对接结果、ADME 预测和体外研究,